Mobidiag and Unilabs enter into agreement over use of Amplidiag product line for molecular gastrointestinal diagnostics
Mobidiag Ltd and Unilabs announced an agreement covering the supply of Amplidiag products over the next four years for Unilabs in Sweden and Norway.
The Amplidiag product line covers six diagnostic products for various gastrointestinal infections, including tests for gastroenteritis, carbapenem- and vancomycin-resistance screening, as well as non-invasive Helicobacter pylori testing. The product line brings a improvement to clinical laboratory processes, patient management and infection control measures by providing sensitive, comprehensive and rapid diagnostic results.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.